Although bumper pads are theoretically designed to prevent injury to a baby while in the crib or bassinet, the risk of accidental death or injury to an infant from using them outweighs their possible benefits, according to a new study by pediatric researchers at Washington University School of Medicine in St. Louis.
Enjoying the eating process without focus on dietary restrictions may be key to managing weight and staying healthy, according to researchers who have unveiled a new and effective model for managing eating.
Scientists in California are reporting an advance toward rapid testing for pre-natal detection of Down syndrome and other birth defects that involve an abnormal number of chromosomes.
The Georgia Institute of Technology and Emory University have received a$1.5 million grant from the National Science Foundation to establish “The Origins Project,” a center for integrated research, education and public outreach focused on the chemistry that may have led to the origin of life.
Clinicians from the Waddell Center for Multiple Sclerosis will conduct MS Symposium 2007: Education, Support and Solutions, a free event for patients, caregivers and health care providers, on Saturday, Oct. 6, at the Oasis Conference Center in Loveland. The Waddell Center is an affiliate of UC Physicians and the Neuroscience Institute at University Hospital and the University of Cincinnati (UC).
Iomai Corporation (Nasdaq: IOMI) announced that travelers who received the company’s patch-based travelers’ diarrhea vaccine were significantly less likely to be sickened as compared with travelers who receive a placebo, according to research presented today by Chief Scientific Officer Gregory Glenn, M.D. at a late-breaker presentation during the “Vaccines and Pediatric Infections” session of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy being held in Chicago.
The Bill & Melinda Gates Foundation announced grants totaling $280 million to help fight tuberculosis, an epidemic that infects one-third of people on earth and kills nearly 2 million yearly—mostly in the poorest countries.
Results of the first-ever clinical study in patients with osteoporosis who suffered a hip fracture show that a once-yearly infusion of Aclasta®/Reclast® (zoledronic acid 5 mg)[*] reduced the risk of subsequent fractures by 35% compared to patients treated with placebo.
Scientists have discovered how the gene mutation responsible for fragile X syndrome — the most common inherited form of mental retardation — alters the way brain cells communicate. In neurons cultured from laboratory rats, the scientists also were able to reverse the effects of the mutation using a drug targeted to the specific site in an upstream pathway of the defect. The finding could lead to the development of human therapies for this previously untreatable condition.
New research from Rockefeller University and the Howard Hughes Medical Institute uncovers a new pathway that regulates caspase activity in Drosophila sperm, a finding that may provide new opportunities to develop drugs that can alter cell death for therapeutic purposes.